SCI时时刷

search
+
Valvular heart disease in patients with cardiac amyloidosis
Valvular heart disease in patients with cardiac amyloidosis
Cardiac amyloidosis (CA) is an underdiagnosed condition caused by the deposition of misfolded proteins, namely immunoglobu...
Patient phenotype profiling using echocardiography and natriuretic peptides to personalise heart failure therapy
Patient phenotype profiling using echocardiography and natriuretic peptides to personalise heart failure therapy
Heart failure (HF) is a progressive condition with a clinical picture resulting from reduced cardiac output (CO) and/or el...
Stem cell-based therapies for heart failure management: a narrative review of current evidence and future perspectives
Stem cell-based therapies for heart failure management: a narrative review of current evidence and future perspectives
Heart failure (HF) is a prevalent and debilitating global cardiovascular condition affecting around 64 million individuals...
Assessment and management of heart failure in patients with chronic kidney disease
Assessment and management of heart failure in patients with chronic kidney disease
Heart failure (HF) and chronic kidney disease (CKD) are two pathological conditions with a high prevalence in the general ...
The sympathetic nervous system in heart failure revisited
The sympathetic nervous system in heart failure revisited
Several attempts have been made, by the scientific community, to develop a unifying hypothesis that explains the clinical ...
Hyponatremia and takotsubo syndrome: a review of pathogenetic and clinical implications
Hyponatremia and takotsubo syndrome: a review of pathogenetic and clinical implications
Hyponatremia is a common electrolyte abnormality with important prognostic and therapeutic implications. It might exert de...
Predictive biomarkers for the early detection and management of heart failure
Predictive biomarkers for the early detection and management of heart failure
Cardiovascular disease (CVD) is a serious public health concern whose incidence has been on a rise and is projected by the...
Call for candidates: Editor-in-Chief for the Heart Failure Reviews
Call for candidates: Editor-in-Chief for the Heart Failure Reviews
The publisher Springer is seeking applications and nominations for the position of th...
Cardiopulmonary exercise testing criteria for advanced therapies in patients with heart failure
Cardiopulmonary exercise testing criteria for advanced therapies in patients with heart failure
Many cardiology associations endorse the role of the cardiopulmonary exercise test (CPET) to define the severity of impair...
Sex differences in transthyretin cardiac amyloidosis
Sex differences in transthyretin cardiac amyloidosis
Transthyretin cardiac amyloidosis (ATTR-CA) is a progressive disease characterized by the deposition of abnormal transthyr...
Advance of echocardiography in cardiac amyloidosis
Advance of echocardiography in cardiac amyloidosis
Cardiac amyloidosis (CA) occurs when the insoluble fibrils formed by misfolded precursor proteins deposit in cardiac tissu...
Cost-effectiveness of cardiovascular magnetic resonance imaging compared to common strategies in the diagnosis of coronary artery disease: a systematic review
Cost-effectiveness of cardiovascular magnetic resonance imaging compared to common strategies in the diagnosis of coronary artery disease: a systematic review
Cardiovascular magnetic resonance imaging (CMR) has established exceptional diagnostic utility and prognostic value in cor...
Understanding the role of coronary artery revascularization in patients with left ventricular dysfunction and multivessel disease
Understanding the role of coronary artery revascularization in patients with left ventricular dysfunction and multivessel disease
Coronary artery disease (CAD) is the most common cause of heart failure with reduced ejection fraction (HFrEF). Advances a...
Lipoprotein(a) and heart failure: a systematic review
Lipoprotein(a) and heart failure: a systematic review
The role of lipoprotein(a) [Lp(a)] as a possible causal risk factor for atherosclerotic artery disease and aortic valve st...
The prediction model of the short-term outcome in elderly heart failure patients
The prediction model of the short-term outcome in elderly heart failure patients
This study was designed to investigate the effect of the comprehensive geriatric assessment on the short-term prognosis of...
A novel opportunity to improve heart failure care: focusing on subcutaneous furosemide
A novel opportunity to improve heart failure care: focusing on subcutaneous furosemide
The prevalence of heart failure (HF) continues to rise in developed nations. Symptomatic congestion is the most common rea...
Acute mitral regurgitation with and without acute heart failure
Acute mitral regurgitation with and without acute heart failure
Acute severe mitral regurgitation (MR) is rare, but often leads to cardiogenic shock, pulmonary edema, or both. Most commo...
ACEI/ARB and beta-blocker therapies for preventing cardiotoxicity of antineoplastic agents in breast cancer: a systematic review and meta-analysis
ACEI/ARB and beta-blocker therapies for preventing cardiotoxicity of antineoplastic agents in breast cancer: a systematic review and meta-analysis
Anthracyclines and trastuzumab are widely used to treat breast cancer but increase the risk of cardiomyopathy and heart fa...
Correction to: Acute advanced aortic stenosis
Correction to: Acute advanced aortic stenosis
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which ...
Sex-specific differences in the efficacy of heart failure therapies: a meta-analysis of 84,818 patients
Sex-specific differences in the efficacy of heart failure therapies: a meta-analysis of 84,818 patients
Women have been historically underrepresented in clinical trials of heart failure (HF). We aimed to assess for sex differe...
Choosing wisely: incorporating appropriate donor-recipient size matching in heart transplantation
Choosing wisely: incorporating appropriate donor-recipient size matching in heart transplantation
Historically, transplantation of a female donor heart to male recipient has been viewed with caution given evidence of sub...
Right ventricular failure in left heart disease: from pathophysiology to clinical manifestations and prognosis
Right ventricular failure in left heart disease: from pathophysiology to clinical manifestations and prognosis
Right heart failure (RHF) is a clinical syndrome in which symptoms and signs are caused by dysfunction and/or overload of ...
Association between sodium-glucose cotransporter-2 inhibitors and incident atrial fibrillation/atrial flutter in heart failure patients with reduced ejection fraction: a meta-analysis of randomized controlled trials
Association between sodium-glucose cotransporter-2 inhibitors and incident atrial fibrillation/atrial flutter in heart failure patients with reduced ejection fraction: a meta-analysis of randomized controlled trials
Atrial fibrillation (AF) and atrial flutter (AFL) are associated with adverse outcomes in patients with heart failure and ...
Does omega-3 supplementation improve the inflammatory profile of patients with heart failure? a systematic review and meta-analysis
Does omega-3 supplementation improve the inflammatory profile of patients with heart failure? a systematic review and meta-analysis
Omega-3 fatty acids are potential anti-inflammatory agents that may exert beneficial outcomes in diseases characterised by...
The prognostic value of right ventricular longitudinal strain in heart failure: a systematic review and meta-analysis
The prognostic value of right ventricular longitudinal strain in heart failure: a systematic review and meta-analysis
Background: Right ventricular (RV) dysfunction is a well-recognized adverse prognostic feature in patients with heart fail...
Guideline-directed medical therapy for HFrEF: sequencing strategies and barriers for life-saving drug therapy
Guideline-directed medical therapy for HFrEF: sequencing strategies and barriers for life-saving drug therapy
Multiple landmark trials have helped to advance the treatment of heart failure with reduced ejection fraction (HFrEF) sign...
Efficacy and safety of sodium-glucose cotransporter-2 inhibitors in heart failure with mildly reduced or preserved ejection fraction: an overview of 36 systematic reviews
Efficacy and safety of sodium-glucose cotransporter-2 inhibitors in heart failure with mildly reduced or preserved ejection fraction: an overview of 36 systematic reviews
The recently published randomized trials (RCTs) evaluating the effect of Sodium-glucose cotransporter-2 inhibitors (SGLT2i...
High-intensity interval training versus moderate-intensity continuous training in patients with heart failure: a systematic review and meta-analysis
High-intensity interval training versus moderate-intensity continuous training in patients with heart failure: a systematic review and meta-analysis
The effects of high-intensity interval training (HIIT) in patients with heart failure (HF) remain controversial. This syst...
Endocardial fibroelastosis in infants and young children: a state-of-the-art review
Endocardial fibroelastosis in infants and young children: a state-of-the-art review
Endocardial fibroelastosis (EFE) is a rare cardiac condition characterized by excessive endocardial thickening secondary t...
Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction?
Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction?
Heart failure (HF) with preserved ejection fraction (HFpEF) causes a progressive limitation of functional capacity, poor q...
阅读更多
format_indent_increase